结论：肝癌特异性多柔比星免疫磷脂纳米粒，有可能成为一种新的药物靶向载体系统。
Conclusion: Doxorubicin phospholipid nanoparticle is able to become a new drug targeting carrier system.
基因治疗已在治疗多种人类重大疾病如遗传病、肿瘤等方面显示出良好的应用前景，但也面临着巨大的挑战，主要是如何选择安全、高效、靶向的载体系统。
Gene therapy has shown great potentials in the treatment of a number of human key diseases, such as genetic diseases, cancer and so on, yet there are still some big challenges to face.
应用推荐